Table 6.
Examples of multicellular static and microfluidic liver models for absorption, distribution, metabolism, excretion, and toxicity (ADMET) testing
Model | Application | Advantage | Disadvantage | References |
---|---|---|---|---|
Static models | ||||
Co-culture spheroids | Stellate cell activation | Long term 3D culturing with improved drug metabolism and output of albumin, urea | Specialized plates to from spheroids, specialized culturing techniques | 67 |
Co-culture micropatterned primary hepatocytes with fibroblasts | Hepatotoxicity Metabolite ID Disease models | Hepatocytes maintain differentiated function 2–3 wk | 2D cultures, specialized plates | 65,68 |
Four-cell spheroids primary hepatocytes, primary liver NPC | Hepatotoxicity Metabolite ID | Hepatocytes maintain differentiated function >3 wk, 3D, immune-mediated toxicity | Specialized culturing techniques | 69 |
3D microfluidic, multicellular liver models | ||||
Primary hepatocytes, endothelial cells | Hepatotoxicity | Hepatocytes maintain differentiated function >3 wk, microfluidic improves function | Specialized culturing techniques, perfusion system | 70 |
Hepatocytes, endothelial cells, stellate cells, Kupffer-like immune cells | PK, toxicity, therapeutic intervention, liver disease model | Hepatocytes maintain differentiated function >3 wk, immune-mediated toxicity, fibrosis activation microfluidic improves function | Specialized culturing techniques, perfusion system | 48,51,71 |
Abbreviations: 2D, 2 dimensional; 3D, 3 dimensional; NPC, non parenchymal cells; PK, pharmacokinetic.